FM
Fady Ibraham Malik (EVP Research & Development) filed 19 Form 4 reports in the trailing twelve months (0 purchases, 19 sales), most often in Cytokinetics, Incorporated (CYTK). The largest single filing was $748K of CYTK (12,033 sh across 2 lots, as filed), executed Mar 17. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
19
0 buys · 19 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.7M
shares × price, as filed
Last traded
Nov 3
Filed Nov 3
Median ADV $207.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $6.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
19 filings
Sector per market data · by filing · past 12 months
Most traded names
CYTKRecent filings
CYTKSALE
Cytokinetics, Incorporated
View filing →
$356K8,228 sh × $43.27
Exec Mar 6 2025
Filed Mar 7 2025 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $105K
2,449 sh × $42.88
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $370K
7,300 sh across 2 lots
Exec Dec 10 2024
Filed Dec 10 2024 · 5:30 PM ET CYTKSALE Cytokinetics, Incorporated View filing → $366K
7,300 sh across 2 lots
Exec Nov 26 2024
Filed Nov 26 2024 · 5:30 PM ET